Patent Assignment
Reel/Frame 058310/0872
Assignment of Assignor's Interest
Recorded: 2021-12-06
Pages: 3
Assignor
HUA, YIMIN
Executed: 2021-02-04
Assignee
ACCUTAR BIOTECHNOLOGY INC.
760 PARKSIDE AVENUE, ROOM 213, BROOKLYN, NEW YORK, 11226
Covered Property
(1)
Antisense Oligonucleotides and Their Use for Treating Pendred Syndrome
Patent:
11,312,959 →
Application:
17/173,864 →
Publication:
US 2021/0246449
PCT:
PCT/US2021/017595 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 6, 2021
From: ACCUTAR BIOTECHNOLOGY INC.
To: HUA, YIMIN
Reel/Frame 058310/0972 →
Assignment of Assignor's Interest
Dec 6, 2021
From: HUA, YIMIN
To: ASOCURA PHARMACEUTICALS SUZHOU CO., LTD.
Reel/Frame 058311/0117 →
Change of Name
Jun 10, 2026
From: ASOCURA PHARMACEUTICALS SUZHOU CO., LTD
To: ASOCURA PHARMACEUTICALS GUANGZHOU CO., LTD
Reel/Frame 074915/0310 →